284 related articles for article (PubMed ID: 25421478)
21. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship study of peptidomimetic aldehydes as enterovirus 71 3C protease inhibitors.
Zhai Y; Ma Y; Ma F; Nie Q; Ren X; Wang Y; Shang L; Yin Z
Eur J Med Chem; 2016 Nov; 124():559-573. PubMed ID: 27614190
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.
Ramajayam R; Tan KP; Liu HG; Liang PH
Bioorg Med Chem; 2010 Nov; 18(22):7849-54. PubMed ID: 20947359
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
25. 3C protease of enterovirus 71 cleaves promyelocytic leukemia protein and impairs PML-NBs production.
Li Z; Wu Y; Li H; Li W; Tan J; Qiao W
Virol J; 2021 Dec; 18(1):255. PubMed ID: 34930370
[TBL] [Abstract][Full Text] [Related]
26. Fisetin and rutin as 3C protease inhibitors of enterovirus A71.
Lin YJ; Chang YC; Hsiao NW; Hsieh JL; Wang CY; Kung SH; Tsai FJ; Lan YC; Lin CW
J Virol Methods; 2012 Jun; 182(1-2):93-8. PubMed ID: 22465253
[TBL] [Abstract][Full Text] [Related]
27. Development of anti-coxsackievirus agents targeting 3C protease.
Kim BK; Kim JH; Kim NR; Lee WG; Lee SD; Yun SH; Jeon ES; Kim YC
Bioorg Med Chem Lett; 2012 Nov; 22(22):6952-6. PubMed ID: 23062551
[TBL] [Abstract][Full Text] [Related]
28. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
[TBL] [Abstract][Full Text] [Related]
29. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
[TBL] [Abstract][Full Text] [Related]
30. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71.
Wu C; Zhang L; Li P; Cai Q; Peng X; Yin K; Chen X; Ren H; Zhong S; Weng Y; Guan Y; Chen S; Wu J; Li J; Lin T
Biochim Biophys Acta; 2016 Jun; 1860(6):1299-307. PubMed ID: 26987809
[TBL] [Abstract][Full Text] [Related]
31. Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.
Wang CY; Huang AC; Hour MJ; Huang SH; Kung SH; Chen CH; Chen IC; Chang YS; Lien JC; Lin CW
Viruses; 2015 Jun; 7(6):3155-71. PubMed ID: 26090728
[TBL] [Abstract][Full Text] [Related]
32. Activity-Based Protein Profiling Identifies ATG4B as a Key Host Factor for Enterovirus 71 Proliferation.
Sun Y; Zheng Q; Wang Y; Pang Z; Liu J; Yin Z; Lou Z
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554687
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents.
Kuo CJ; Shie JJ; Fang JM; Yen GR; Hsu JT; Liu HG; Tseng SN; Chang SC; Lee CY; Shih SR; Liang PH
Bioorg Med Chem; 2008 Aug; 16(15):7388-98. PubMed ID: 18583140
[TBL] [Abstract][Full Text] [Related]
34. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses.
Wang B; Xi X; Lei X; Zhang X; Cui S; Wang J; Jin Q; Zhao Z
PLoS Pathog; 2013 Mar; 9(3):e1003231. PubMed ID: 23555247
[TBL] [Abstract][Full Text] [Related]
35. The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir.
Lacroix C; George S; Leyssen P; Hilgenfeld R; Neyts J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5814-8. PubMed ID: 26055377
[TBL] [Abstract][Full Text] [Related]
36. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
[TBL] [Abstract][Full Text] [Related]
37. α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.
Zhang L; Lin D; Kusov Y; Nian Y; Ma Q; Wang J; von Brunn A; Leyssen P; Lanko K; Neyts J; de Wilde A; Snijder EJ; Liu H; Hilgenfeld R
J Med Chem; 2020 May; 63(9):4562-4578. PubMed ID: 32045235
[TBL] [Abstract][Full Text] [Related]
38. Biochemical characterization of recombinant Avihepatovirus 3C protease and its localization.
Sun D; Wang M; Wen X; Mao S; Cheng A; Jia R; Yang Q; Wu Y; Zhu D; Chen S; Liu M; Zhao X; Zhang S; Chen X; Liu Y; Yu Y; Zhang L
Virol J; 2019 Apr; 16(1):54. PubMed ID: 31036013
[TBL] [Abstract][Full Text] [Related]
39. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of irreversible inhibitors of foot-and-mouth disease virus 3C protease.
Roqué Rosell NR; Mokhlesi L; Milton NE; Sweeney TR; Zunszain PA; Curry S; Leatherbarrow RJ
Bioorg Med Chem Lett; 2014 Jan; 24(2):490-4. PubMed ID: 24374278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
